Revenue: The sum of all revenue fields included for a company's operating activities.
Teva Pharmaceutical Industries Ltd. (TEVA) had Revenue of $4.46B for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$4.46B |
$429.00M |
|
$2.04B |
|
$2.42B |
|
$3.73B |
|
$722.00M |
|
$-249.00M |
|
$473.00M |
|
$473.00M |
|
$433.00M |
|
$436.00M |
|
$433.00M |
|
$433.00M |
|
$722.00M |
|
$988.00M |
|
1.12B |
|
1.12B |
|
$0.38 |
|
$0.38 |
|
| Balance Sheet Financials | |
$12.48B |
|
$5.75B |
|
$30.99B |
|
$43.48B |
|
$12.25B |
|
$18.16B |
|
$23.11B |
|
$35.35B |
|
$8.12B |
|
$-14.44B |
|
$8.13B |
|
1.12B |
|
| Cash Flow Statement Financials | |
$1.37B |
|
$968.00M |
|
$-1.91B |
|
$2.83B |
|
$3.23B |
|
$393.00M |
|
$121.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
0.69 |
|
2.44 |
|
54.21% |
|
16.20% |
|
16.20% |
|
-- |
|
10.61% |
|
9.63% |
|
$910.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.51 |
|
1.31 |
|
68.82 |
|
5.37% |
|
-3.02% |
|
1.00% |
|
1.66% |
|
$7.25 |
|
$0.81 |
|
$1.22 |
|